Health

Results: 1-12 of 10100

KFSH Extends Emergency Access Through Virtual Care and Specialist Coordination

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 2026

Boots Group Finco L.P. and The Boots Group Luxco S.à r.l. Announce Expiration and Results of the Consent Solicitation for their €650,000,000 5.375% Senior Secured Notes due 2032 and £375,000,000 7.375% Senior Secured Notes due 2032

Hansa Biopharma announces positive Idefirix PAES results presented in the High-Impact Clinical Trials session at ASN Kidney Week

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 2026

PR Newswire associated0

Congruence Therapeutics Announces Oral Presentation on CGX-195, a Novel Small Molecule AAT Corrector, at the ERS Alpha-1 Antitrypsin (AAT) Conference 2026

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer

XBiotech Announces Election of Sushma Shivaswamy and Jan-Paul Simard as Co-Chief Executive Officers

Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.

Takeda Announces Arcotatug Tavatecan (TAK-921) Demonstrated Statistically Significant and Clinically Meaningful Improvements in Overall Survival and Progression-Free Survival in Phase 3 Advanced Gastric Cancer Study

KFSH Cuts the Wait for an Echocardiography Appointment from 126 Days to One

Galderma’s Relfydess™ (relabotulinumtoxinA) Receives Approval in China for Frown Lines